AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitalembic M 100/1000 SR Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitalembic M 100/1000 SR Tablet

Diabetics with type 2 mellitus may benefit from Duo-Control SR tablets, a dual-action medication managing elevated blood glucose. This helps mitigate serious diabetic complications, such as vision impairment and renal damage, and potentially lowers cardiovascular event risk. Duo-Control SR may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and consistent exercise. Dosage is individualized, considering your health status, glucose levels, and current medications. Consuming the tablets with food minimizes gastrointestinal discomfort. For maximum efficacy, maintain a consistent daily intake schedule; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise regimen is crucial for diabetes management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and throat irritation. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn how to recognize and manage this. This medication isn't suitable for everyone. Consult your doctor before use if you have a history of hepatic, renal, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical advice prior to use. Inform your doctor of all medications you are taking to avoid potential interactions. Alcohol should be avoided due to its hypoglycemic effect. Your physician will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitalembic M 100/1000 SR Tablet

Managing type 2 diabetes

Major Benefits of Sitalembic M 100/1000 SR Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the Sitalembic M 100/1000 SR Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitalembic M 100/1000 SR Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitalembic M 100/1000 SR Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Sitalembic M 100/1000 SR Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Sitalembic M 100/1000 SR Tablet works:

Sitalembic M 100/1000 SR tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitalembic M 100/1000 SR Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitalembic M 100/1000 SR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitalembic M 100/1000 SR Tablet while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitalembic M 100/1000 SR Tablets, as dosage modification may be necessary. A physician's consultation is recommended. The medication is contraindicated in individuals with severe renal dysfunction. Consistent monitoring of renal function is prudent during treatment.

LiverLiverUNSAFE

Use of Sitalembic M 100/1000 SR Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Sitalembic M 100/1000 SR Tablet :

Should you forget a Sitalembic M 100/1000 SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitalembic M 100/1000 SR Tablet

LabelValue
Addictive None.
Medication Classification Diabetes medication

FAQs on Sitalembic M 100/1000 SR Tablet

Sitalembic M 100/1000 SR Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin blocks DPP-4, boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitalembic M 100/1000 SR Tablets can indeed lead to vitamin B12 deficiency. This is due to the medication's impact on the stomach's ability to absorb vitamin B12. Untreated deficiency may result in anemia and neurological complications, manifesting as tingling or numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some experts.
Sitalembic M 100/1000 SR Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis may occur. Prolonged use might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitalembic M 100/1000 SR Tablet constituent or inactive ingredient should not use this medication. Its use is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 100/1000 SR Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Store the medication in its original, tightly sealed container, following the storage directions provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Sitalembic M 100/1000 SR Tablet use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this infrequent adverse reaction necessitates avoiding the medication in individuals with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Sitalembic M 100/1000 SR Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when used with a suitable diet and exercise regimen. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin's mechanism involves DPP4 enzyme inhibition, thereby boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitalembic M 100/1000 SR Tablet may cause common adverse reactions including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects such as lactic acidosis may occur. Prolonged administration can result in vitamin B12 deficiency.
Patients with hypersensitivity to Sitalembic M 100/1000 SR Tablet constituents or inactive ingredients should not use this medication. Similarly, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 100/1000 SR Tablet with alcohol is unsafe and raises the risk of lactic acidosis.
Sitalembic M 100/1000 SR Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This, also termed Metformin-associated lactic acidosis (MALA), is an uncommon adverse reaction to metformin. Consequently, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Lactic acidosis symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Indeed, prolonged use of Sitalembic M 100/1000 SR Tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some experts on at least an annual basis.
Store this medication in its original, tightly sealed container, following all storage directions printed on the packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitalembic M 100/1000 SR Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when coupled with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity. Sitagliptin blocks DPP4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Sitalembic M 100/1000 SR Tablet may cause common adverse reactions including low blood glucose, taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory illness. Rare but potentially severe reactions such as lactic acidosis may also occur. Prolonged therapy might result in vitamin B12 insufficiency.
Patients with hypersensitivity to any Sitalembic M 100/1000 SR Tablet constituent or inactive ingredient should not take this medication. Its administration is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitalembic M 100/1000 SR Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitalembic M 100/1000 SR Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this uncommon side effect of metformin necessitates avoidance in individuals with kidney impairment, advanced age, or significant alcohol consumption. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Sitalembic M 100/1000 SR Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some studies.
Retain this medication in its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitalembic M 100/1000 SR ...
194
MRP 225
13% off